In a pooled analysis of SOLOIST-WHF and EMPULSE, SGLT2 inhibitors significantly reduced the composite of total CV mortality or HF hospitalization/HF event across all three statistical models (Supplemental Figure S60). Here, SLC5A2 is linked to hydrops fetalis.